Cargando…
Full eradication of pre‐clinical human papilloma virus‐induced tumors by a lentiviral vaccine
Human papillomavirus (HPV) infections are the cause of all cervical and numerous oropharyngeal and anogenital cancers. The currently available HPV vaccines, which induce neutralizing antibodies, have no therapeutic effect on established tumors. Here, we developed an immuno‐oncotherapy against HPV‐in...
Autores principales: | Douguet, Laëtitia, Fert, Ingrid, Lopez, Jodie, Vesin, Benjamin, Le Chevalier, Fabien, Moncoq, Fanny, Authié, Pierre, Nguyen, Trang‐My, Noirat, Amandine, Névo, Fabien, Blanc, Catherine, Bourgine, Maryline, Hardy, David, Anna, François, Majlessi, Laleh, Charneau, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565635/ https://www.ncbi.nlm.nih.gov/pubmed/37675835 http://dx.doi.org/10.15252/emmm.202317723 |
Ejemplares similares
-
Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses
por: Nemirov, Kirill, et al.
Publicado: (2023) -
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa
por: Vesin, Benjamin, et al.
Publicado: (2022) -
Brain cross‐protection against SARS‐CoV‐2 variants by a lentiviral vaccine in new transgenic mice
por: Ku, Min‐Wen, et al.
Publicado: (2021) -
Lentiviral vector induces high-quality memory T cells via dendritic cells transduction
por: Ku, Min Wen, et al.
Publicado: (2021) -
Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters
por: Vesin, Benjamin, et al.
Publicado: (2022)